NCT07730892

Brief Summary

Few studies compared PCNL and RIRS for stones in solitary kidney. Current guidelines do not provide clear recommendations concerning the management of renal stones in patients with solitary kidney. The study aims to compare the safety and efficacy of the use of percutaneous nephrolithotomy (PCNL) and flexible ureteroscopy in the treatment of renal stones \_ ≤ 3 cm in largest diameter through a prospective non randomized study in the period between August 2024 and August 2026. Stone-free rate will be assessed by NCCT done at 1st day postoperative and after 3 months. For Evaluation of kidney function postoperatively, creatinine clearance will be done after 1month and renal isotope scan will be done after 3 months. In addition, the results will be compared to the data of the patients with solitary kidney and renal stones who were retrospectively treated by PCNL or RIRS in the period between 2002 and 2024. The cases should fulfil the same inclusion criteria of the prospective study.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
83

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Nov 2024Oct 2026

Study Start

First participant enrolled

November 23, 2024

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

July 5, 2026

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 28, 2026

Completed
4 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Expected
Last Updated

July 28, 2026

Status Verified

July 1, 2026

Enrollment Period

1.7 years

First QC Date

July 5, 2026

Last Update Submit

July 23, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • stone free rate

    Stone-free status: it will be assessed by NCCT (defined as the absence of any stones or presence of only clinically insignificant residual stones \< 4 mm as measured by NCCT). Sub classified to * Initial stone free rate (1st day postoperative) * Final stone free rate (after 3 months)

    within 3 months after surgery

Secondary Outcomes (7)

  • complication rate

    within 30 days after surgery

  • number of sessions

    3 months after surgery

  • renal function evaluation

    within 3 months after surgery

  • auxiliary procedures

    within 3 months after surgery

  • hospital stay

    from date of surgery until hospital discharge ( up to 30 days )

  • +2 more secondary outcomes

Study Arms (2)

RIRS

EXPERIMENTAL

patients undergo retrograde intrarenal surgery (RIRS) for management of stones in solitary kidney

Procedure: retrograde intra renal surgery (RIRS)

PCNL

EXPERIMENTAL

patients undergo percutaneous nephrolithotomy (PCNL) for management of stones in solitary kidney

Procedure: percutaneous nephrolithotomy (PCNL)

Interventions

standard retrograde intrarenal surgery (RIRS) for management of stones in solitary kidney

RIRS

standard percutaneous nephrolithotomy (PCNL) for management of stones in solitary kidney

PCNL

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with anatomical or functional solitary kidney.
  • Renal stones ≤ 3 cm in largest diameter- as measured by non-contrast spiral CT
  • Age ≥ 18 years.

You may not qualify if:

  • Patients who did not meet the above criteria.
  • bleeding diathesis or those on anticoagulant therapy.
  • concomitant pathology as ureteric stricture or renal congenital anomalies .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Urology and Nephrology center , Mansoura University

Al Mansurah, Dakahlia Governorate, 35516, Egypt

Location

MeSH Terms

Conditions

Nephrolithiasis

Interventions

Nephrolithotomy, Percutaneous

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

LaparoscopyEndoscopyMinimally Invasive Surgical ProceduresSurgical Procedures, OperativeUrologic Surgical ProceduresUrogenital Surgical Procedures

Study Officials

  • Ahmed M. Shoma, Professor of urology

    Urology and Nephrology Center , Mansoura university , Egypt

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2026

First Posted

July 28, 2026

Study Start

November 23, 2024

Primary Completion

August 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

July 28, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations